Search

everythinglearnresearchcommunity

for

Search:↓

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Melatonin in the skin helps protect against damage from stress and UV rays, and could be used to treat certain skin conditions.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Early development of hair, teeth, and glands involves specific signaling pathways and cellular interactions.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Nerves and chemicals in the body can affect hair growth and loss.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Researchers identified genes linked to coat color, body size, cashmere production, and high altitude adaptation in goats.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Testosterone may slow down wound healing and increase inflammation.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

Endo-HSE helps grow hair-like structures from human skin cells in the lab.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.